James Mond
2012
In 2012, James Mond earned a total compensation of $896.9K as Chief Scientific and Medical Officer at ADMA Biologics.
Compensation breakdown
| Bonus | $52,000 |
|---|---|
| Option Awards | $729,900 |
| Salary | $115,000 |
| Total | $896,900 |
Mond received $729.9K in option awards, accounting for 81% of the total pay in 2012.
Mond also received $52K in bonus and $115K in salary.
Rankings
In 2012, James Mond's compensation ranked 6,569th out of 11,487 executives tracked by ExecPay. In other words, Mond earned more than 42.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,569 out of 11,487 | 43rd |
Division Manufacturing | 2,356 out of 4,253 | 45th |
Major group Chemicals And Allied Products | 595 out of 1,198 | 50th |
Industry group Drugs | 408 out of 920 | 56th |
Industry Biological Products, Except Diagnostic Substances | 65 out of 160 | 59th |
Source: SEC filing on April 29, 2014.
Mond's colleagues
We found two more compensation records of executives who worked with James Mond at ADMA Biologics in 2012.
News
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019